ANA dysfunction score was significantly higher in patients with achalasia than that of control (P-value= 0.035). There were no statistical differences in standard deviation of all normal RR intervals, high frequency (HF), low frequency (LF), LF/HF ratio in HRV test. At subgroup analysis between

female achalasia patients MK-2206 nmr and control, cardiac activity that indicating susceptibility to cardiac overload was significantly higher in female achalasia patients (P-value= 0.036). Cardiac activity (P-value= 0.004) and endurance of stress (P-value= 0.004) were significantly higher in achalasia patient with ANS dysfuction symptoms. Conclusion: ANS dysfuction symptoms are common in patients with achalasia. In this study, achalasia patients with ANS dysfuction symptoms or female gender showed an increased cardiac activity. We should more be paid attention to the cardiac overload in achalasia patient with ANS dysfuction symptoms or female gender. Key Word(s): 1. achalasia; 2. autonomic nerve system; 3. HRV Presenting Author: YUN JU JO Additional Authors: EUN

KYUNG KIM, YEON SOO KIM Corresponding Author: YUN JU JO Affiliations: Eulji University School of Medicine, Seoul National University Objective: The diagnosis of microscopic colitis (MC) relies on identification of histopathological changes such as lymphocytic inflammation or thickened collagenous band in biopsy specimens of colon in patients with chronic diarrhea. The etiology of MC is most likely multifactorial, medchemexpress and some drugs could be caused or worsened MC. There is a lack of information on the long-term prognosis of MC in Asia. We investigated an evidence of inflammatory selleck kinase inhibitor activation and long-term prognosis in the patients with MC. Methods: The patients with chronic loose stool (over 4 weeks) were performed by colonoscopy

and random biopsy of colonic mucosa. We searched for drug consumption, manner of treatements, symptom questionnaire and long-term prognosis by recently telephone interview (from Jan. 2004 to Mar. 2012). Indirect evidences of inflammatory activation were checked by immunohistochemical stain such as TLR4, NOD-2, COX-2 and NK-κB. Results: The prevalence of MC was 12.0% (15/125) in patients with chronic loose stool from Jan. 2004 to Dec. 2009. Average period of treatment was 12.4 month (1 week to 25 months). The consumption of NSAID, ACE inhibitors, calcium antagonists and statin were more frequent in MC than in non-MC group. Especially, NSAID consumption is more related with collagenous colitis. Expression of TLR4 was significantly increased in MC than in non-MC group. Expression of mast cell (CD117) also increased in MC. Clinically, 75–85% of patients in MC were compatable with functional diarrhea in Rome III criteria. Long-term prognosis of MC was favorable in a total of 28 patients, and only 2 patients have taken medication (ramosetron and intermittent loperamide).